Left-ventricular hypertrophy is associated better with 24-h aortic pressure than 24-h brachial pressure in hypertensive patients: The SAFAR study

Journal of Hypertension

Volumn 32, Issue 9, 2014, Pages 1805-1814

  Protogerou, Athanase D ^a   Argyris, Antonis A ^a   Papaioannou, Theodoros G ^b   Kollias, Georgios E ^a   Konstantonis, Giorgos D ^a   Nasothimiou, Efthimia ^a   Achimastos, Apostolos ^c   Blacher, Jacques ^d   Safar, Michel E ^d   Sfikakis, Petros P ^a  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c SOTIRIA GENERAL HOSPITAL   (Greece)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

ambulatory blood pressure monitoring; aortic blood pressure; left ventricular hypertrophy

Indexed keywords

ADULT; AORTA PRESSURE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BRACHIAL BLOOD PRESSURE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; PULSE WAVE; AGED; AORTA; ARTERIAL PRESSURE; BLOOD PRESSURE MEASUREMENT; COMPLICATION; DEVICES; MIDDLE AGED; OSCILLOMETRY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TIME;

ADULT; AGED; AORTA; ARTERIAL PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; OSCILLOMETRY; PULSE WAVE ANALYSIS; TIME FACTORS;

EID: 84906064659     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000263     Document Type: Article

References (42)

1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364:937-952
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289:2560-2572
3. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 7:1281-1357
4. Blacher J, Evans A, Arveiler D, Amouyel P, Ferrières J, Bingham A, et al. PRIME Study Group Residual cardiovascular risk in treated hypertension and hyperlipidaemia: The PRIME Study. J Hum Hypertens 2010; 24:19-26
5. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al., ACCORD Study Group. Effects of intensive bloodpressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362:1575-1585
6. Protogerou AD, Safar ME, Iaria P, Safar H, Le Dudal K, Filipovsky J, et al. Diastolic blood pressure and mortality in the elderlywith cardiovascular disease. Hypertension 2007; 50:172-180
7. Protogerou AD, Blacher J, Safar M. Isolated systolic hypertension: To Treat or Not To Treat and the role of central haemodynamics. J Hypertens 2013; 31:655-658
8. OBrien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of Hypertension Working Group on Blood PressureMonitoring. European Society of Hypertension recommendations for conventional,ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848
9. Protogerou AD, Papaioannou TG, Blacher J, Papamichael CM, Lekakis JP, Safar ME. Central blood pressures: Do we need them in the management of cardiovascular disease?. Is it a feasible therapeutic target?. J Hypertens 2007; 25:265-272
10. Avolio AP, Van Bortel LM, Boutouyrie P, Cockcroft JR, McEniery CM, Protogerou AD, et al. Role of pulse pressure amplification in arterial hypertension: Experts opinion and review of the data. Hypertension 2009; 54:375-383
11. Vlachopoulos C, Aznaouridis K, ORourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: A systematic review and meta-Analysis. Eur Heart J 2010; 31:1865-1871
12. Agabiti-Rosei E, Mancia G, ORourke MF, Roman MJ, Safar ME, Smulyan H, et al. Central blood pressure measurements and antihypertensive therapy: A consensus document. Hypertension 2007; 50:154-160
13. Protogerou AD, Stergiou GS, Vlachopoulos C, Blacher J, Achimastos A. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: Evidence for specific class-effects of antihypertensive drugs on pressure amplification. Curr Pharm Des 2009; 15:272-289
14. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225
15. Weber T, Wassertheurer S, Rammer M, Maurer E, Hametner B, Mayer CC, et al. Validation of a brachial cuff-based method for estimating central systolic blood pressure. Hypertension 2011; 58:825-832
16. Wilkinson IB, Mc Eniery CN, Cockcroft JR. Central blood pressure estimation for the masses moves a step closer. J Hum Hypertens 2010; 24:495-497
17. Protogerou AD, Smulyan H, Safar ME. Closer to noninvasive out-ofoffice aortic blood pressure assessment: A time to think and act. Hypertension 2011; 58:765-767
18. Protogerou AD, Argyris A, Nasothimiou E, Vrachatis D, Papaioannou TG, Tzamouranis D, et al. Feasibility and reproducibility of noninvasive 24-h ambulatory aortic blood pressure monitoring with a brachial cuffbased oscillometric device. Am J Hypertens 2012; 25:876-882
19. Stergiou GS, Tzamouranis D, Protogerou A, Nasothimiou E, Kapralos C. Validation of the Microlife Watch BP Office professional device for office blood pressure measurement according to the International protocol. Blood Press Monit 2008; 13:299-303
20. Papaioannou TG, Protogerou AD, Stamatelopoulos KS, Vavuranakis M, Stefanadis C. Noninvasive methods and techniques for central blood pressure estimation: Procedures, validation, reproducibility and limitations. Curr Pharm Des 2009; 15:245-253
21. Jones CR, Taylor K, Chowienczyk P, Poston L, Shennan A. A validation of the Mobil O Graph (version 12) ambulatory blood pressure monitor. Blood Press Monit 2000; 5:233-238
22. Franssen PML, Imholz BPM. Evaluation of the Mobil-O-Graph new generation ABPM device using the ESH criteria. Blood Press Monit 2010; 15:229-233
23. Weiß W, Tölle M, Zidek W, Van Der Giet M. Validation of the mobil-OGraph: 24 h-blood pressure measurement device. Blood Press Monit 2010; 15:225-228
24. Wassertheurer S, Mayer CC, Breitencker F. Modeling arterial and left ventricular coupling from noninvasive measurements. Simulat Model Theory Pract 2008; 16:988-997
25. Wassertheurer S, Kropf J, Weber T, Van Der Giet M, Baulmann J, Ammer J, et al. A new oscillometric method for pulse wave analysis: Comparison with a common tonometric method. J Hum Hypertens 2010; 24:498-504
26. Luzardo L, Lujambio I, Sottolano M, Da Rosa A, Thijs L, Noboa O, et al. 24-h ambulatory recording of aortic pulse wave velocity and central systolic augmentation: A feasibility study. Hypertens Res 2012; 35:980-987
27. Weis W, Gohlisch C, Harsch-Gladisch C, Tolle M, Zidek W, Van Der Giet M. Oscillometric estimation of central blood pressure: Validation of the Mobil-O-Graph in comparison with Sphygmocor device. Blood Press Monit 2012; 17:128-131
28. Nunan D, Wassertheurer S, Lasserson D, Hametner B, Fleming S, Ward A, Heneghan C. Assessment of central haemomodynamics from a brachial cuff in a community setting. BMC Cardiovasc Disord 2012; 12:48
29. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for Chamber Quantification: A Report from the American Society of Echocardiographys Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. Eur J Echocardiogr 2006; 7:79-108
30. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566
31. Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zanchetti A. APROS Investigators. Role of echocardiography and carotid ultrasonography in stratifying risk inpatients with essential hypertension: The Assessment of Prognostic Risk Observational Survey. J Hypertens 2002; 20:1307-1314
32. Wachtell K, Okin PM, Olsen MH, Dahlöf B, Devereux RB, Ibsen H, et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: The LIFE Study. Circulation 2007; 116:700-705
33. Jankowski P, Bednarek A, Olszanecka A, Windak A, Kawecka-Jaszcz K, Czarnecka D. Twenty-four-hour profile of central blood pressure and central-To-peripheral systolic pressure amplification. Am J Hypertens 2013; 26:27-33
34. Williams B, Lacy PS, Baschiera F, Brunel P, Düsing R. Novel description of the 24-h circadian rhythms of brachial versus central aortic blood pressure and the impact of blood pressure treatment in a randomized controlled clinical trial: The Ambulatory Central Aortic Pressure (AmCAP) Study. Hypertension 2013; 61:1168-1176
35. Roman MJ, Ganau A, Saba PS, Pini R, Pickering TG, Devereux RB. Impact of arterial stiffening on left ventricular structure. Hypertension 2000; 36:489-494
36. Lekakis JP, Zakopoulos NA, Protogerou AD, Kotsis VT, Papaioannou TG, Stamatelopoulos KS, et al. Cardiac hypertrophy in hypertension: Relation to 24-h blood pressure profile and arterial stiffness. Int J Cardiol 2004; 97:29-33
37. Zhang Y, Li Y, Ding FH, Sheng CS, Huang QF, Wang JG. Cardiac structure and functon in relation to central blood pressure components in Chinese. J Hypertens 2011; 29:2462-2468
38. De Luca N, Asmar RG, London GM, ORourke MF, Safar ME. REASON Project Investigators. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens 2004; 22:1623-1630
39. London GM, Asmar RG, ORourke MF, Safar ME. REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: Comparison with atenolol. J Am Coll Cardiol 2004; 43:92-99
40. Kjeldsen SE, Dahlöf B, Devereux RB, Julius S, Aurup P, Edelman J, et al. LIFE (Losartan Intervention for Endpoint Reduction) Study Group. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: A Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 2002; 288:1491-1498
41. McEniery CM, Yasmin. McDonnell B, Munnery M, Wallace SM, Rowe CV, et al. Anglo-Cardiff Collaborative Trial Investigators. Central pressure: Variability and impact of cardiovascular risk factors: The Anglo-Cardiff Collaborative Trial II. Hypertension 2008; 51:1476-1482
42. Protogerou AD, Papaioannou TG, Sfikakis PP, Blacher J, Karatzis E, Lekakis JP, et al. Differences in pulse pressure day variability between the brachial artery and the aorta in healthy subjects. Artery Res 2012; 6:34-40.